Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Nautilus Biotechnology, Inc. NAUT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.3
-6.5 %
$ 289 M
Market Cap
-4.11
P/E
Price Target
Average
160.87%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--9.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nautilus Biotechnology, Inc.
Wall Street analysts predict an average 1-year price target for
NAUT
of
$6
, with forecasts ranging from a low of
$6
to a high of
$6
.
NAUT Lowest Price Target
Wall Street Target
6 USD
160.87%
NAUT Average Price Target
Wall Street Target
6 USD
160.87%
NAUT Highest Price Target
Wall Street Target
6 USD
160.87%
REVENUE FORECAST
Revenue Forecast Chart
NAUT
EBIT FORECAST
EBIT Forecast Chart
NAUT
NET INCOME FORECAST
Net Income Chart
NAUT
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan